LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,970,000 | -14.5% | 110,000 | -12.0% | 0.98% | -28.5% |
| Q3 2015 | $3,474,000 | +100.8% | 125,000 | -30.6% | 1.37% | +47.8% |
| Q3 2014 | $1,730,000 | +88.5% | 180,000 | +80.0% | 0.92% | +115.9% |
| Q2 2014 | $918,000 | -24.4% | 100,000 | -11.1% | 0.43% | -23.8% |
| Q1 2014 | $1,215,000 | – | 112,500 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |